Cryder Capital Boosts Bets On Alphabet (GOOG), Credit Cards, Health Stocks

Page 2 of 2

Cryder Capital also has 7.50% of its 13F portfolio value invested in Mastercard’s rival Visa Inc. (NYSE:V). The fund holds 154,638 shares of the company valued at $12.79 million at the end of September. While Cryder appears to value the two credit card rivals evenly, Barron’s recently pointed to Visa as being the more attractive of the duo in terms of valuation, with double-digit growth potential. The hedge funds in our system appear to agree with Barron’s, as 115 of them were long Visa on September 30, a total of 31 more than were long Mastercard.

Follow Visa Inc. (NYSE:V)

Cryder Capital boosted its Thermo Fisher Scientific Inc. (NYSE:TMO) holding by 31% during the September quarter, to 164,704 shares valued at $26.20 million. The company recently updated its earning guidance for its fiscal year 2016, with it expecting its full-year EPS to be in the range of $8.19 to $8.30, up from the previous guidance range of $8.07 to $8.20. Thermo Fisher expects its robust acquisition strategy to be its main growth driver. The company maintained its revenue guidance for the fiscal year. 46 hedge funds in our database have long positions in Thermo Fisher Scientific as of September 30, down from 57 a quarter earlier. James Dondero‘s Highland Capital was one of the funds to sell off the stock in Q3, unloading all 27,300 shares of it which the fund had owned on June 30.

Follow Thermo Fisher Scientific Inc. (NYSE:TMO)

Lastly is HCA Holdings Inc (NYSE:HCA), in which Cryder buffed its position by 32% during the September quarter, ending the period with 314,531 shares worth $23.78 million. Following the surprise Presidential victory of Donald Trump, the stock saw a steep decline, as HCA Holdings is a healthcare provider which benefits from Obamacare, which could be dismantled under the Trump regime. Some hedge funds appear to have been fearful of a Trump win in Q3, as the number of funds in our system long HCA declined to 62 as of September 30 from 72 on June 30. Shares of HCA are down by over 10% since Trump’s win, but are still 5% in the green in 2016.

Follow Hca Healthcare Inc. (NYSE:HCA)

Disclosure: None

Page 2 of 2